IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed net income
Net income is the profit left for shareholders after every expense, interest and tax.
IRadimed's net income for the twelve months ending Sep 30, 2026 was $23.98M, up 13.2% year over year. For fiscal 2025 it was $22.48M, up 16.9% from the year before. Over ten years it grew 11.6% a year on average. The highest annual figure on record is $22.48M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.48M | +16.9% |
| FY2024 | Dec 31, 2024 | $19.23M | +11.9% |
| FY2023 | Dec 31, 2023 | $17.19M | +34.0% |
| FY2022 | Dec 31, 2022 | $12.83M | +37.6% |
| FY2021 | Dec 31, 2021 | $9.33M | +581.2% |
| FY2020 | Dec 31, 2020 | $1.37M | -85.8% |
| FY2019 | Dec 31, 2019 | $9.63M | +52.8% |
| FY2018 | Dec 31, 2018 | $6.30M | +1161.3% |
| FY2017 | Dec 31, 2017 | $499.76K | -93.1% |
| FY2016 | Dec 31, 2016 | $7.21M | -4.2% |
| FY2015 | Dec 31, 2015 | $7.53M | +267.2% |
| FY2014 | Dec 31, 2014 | $2.05M | +5.9% |
| FY2013 | Dec 31, 2013 | $1.94M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.51M | +16.7% |
| Q2 FY2026 | Jun 30, 2026 | $5.22M | -9.6% |
| Q1 FY2026 | Mar 31, 2026 | $5.82M | +24.1% |
| Q4 FY2025 | Dec 31, 2025 | $6.44M | +25.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.58M | +10.4% |
| Q2 FY2025 | Jun 30, 2025 | $5.77M | +17.8% |
| Q1 FY2025 | Mar 31, 2025 | $4.69M | +13.3% |
| Q4 FY2024 | Dec 31, 2024 | $5.15M | +13.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.05M | -0.3% |
| Q2 FY2024 | Jun 30, 2024 | $4.90M | +17.3% |
| Q1 FY2024 | Mar 31, 2024 | $4.14M | +21.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.54M | +23.6% |
| Q3 FY2023 | Sep 30, 2023 | $5.07M | +47.9% |
| Q2 FY2023 | Jun 30, 2023 | $4.18M | +29.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.41M | +37.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.67M | -5.6% |
| Q3 FY2022 | Sep 30, 2022 | $3.43M | +33.0% |
| Q2 FY2022 | Jun 30, 2022 | $3.24M | +120.5% |
| Q1 FY2022 | Mar 31, 2022 | $2.49M | +79.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.89M | +510.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.58M | +139.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.47M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.39M | -21.6% |
| Q4 FY2020 | Dec 31, 2020 | $637.41K | -80.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.07M | -56.2% |
| Q2 FY2020 | Jun 30, 2020 | -$2.11M | -201.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.77M | -4.1% |
| Q4 FY2019 | Dec 31, 2019 | $3.24M | +89.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.45M | +2.3% |
| Q2 FY2019 | Jun 30, 2019 | $2.09M | +54.2% |
| Q1 FY2019 | Mar 31, 2019 | $1.85M | +119.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.71M | +829.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.40M | +1147.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.35M | +279.5% |
| Q1 FY2018 | Mar 31, 2018 | $841.20K | – |
| Q4 FY2017 | Dec 31, 2017 | $183.64K | -83.9% |
| Q3 FY2017 | Sep 30, 2017 | $192.39K | – |
| Q2 FY2017 | Jun 30, 2017 | $357.07K | – |
| Q1 FY2017 | Mar 31, 2017 | -$233.34K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.14M | – |
See a number that looks wrong?